glucagon agonist retatrutide A phase 2 clinical trial demonstrates that #retatrutide, a triple of the GIP, GLP-1, and receptors, results in up to 82% reduction in liver fat #MASLD @ArunJSanyalVCU Retatrutide Triple Agonist (GLP-1/GIP/GCG) |
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11

























